ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2026
Optimising the atrial fibrillation ablation pathway using vascular closure devices: effects on length of stay, procedure time and outcomes.
Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathways, prevention, and patient counseling.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe rising prevalence of atrial fibrillation has led to increasing the numbers of pulmonary vein isolations. Optimising care pathway efficiency is essential for sustainable healthcare delivery. This study aimed to evaluate the impact of closure devices (CD) within the care pathway on hospital stay, patient satisfaction, staff workload, and costs, following catheter ablation for atrial fibrillation.
methodsThis study compared the standard care pathway following catheter ablation using manual compression (MC, December 2023-February 2024) to a modified pathway incorporating suture-mediated CD (March-May 2024). Primary outcomes included process indicators (e.g., hospitalisation duration), clinical outcomes (e.g., bleeding complications), and patient experience. Secondary outcomes included staff experience and healthcare costs associated with procedural changes.
resultsA total of 159 patients participated (MC: 81 patients, CD: 78 patients). Patients received an average of 2 percutaneous sutures. Treatment with CDs resulted in a 3.7-hour reduction in hospitalisation duration (p <. 001), 10-minute shorter procedure time in first-time ablations (p = .006), and 4‑hour shorter bed rest (p <. 001). Patients experienced less pain, measured using the Numeric Rating Scale (median 3 vs 1, p = .001), and used less pain medication (p = .006). Discharge comfort was higher in the CD group (p = .009), while complication rates remained similar. 24 nurses participated in the questionnaire. Most nurses reported improved time efficiency and workday organisation. Costs were similar across groups.
conclusionCDs improve care pathways after atrial fibrillation ablation by reducing hospitalisation time, enhancing patient comfort, and improving workflow efficiency without increasing complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.